Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects

Archives of Medical Research

Volumn 36, Issue 4, 2005, Pages 362-366

  Rodríguez Hernández, Heriberto ^a   Gonzalez, José Luis ^a   Rodríguez Morán, Martha ^a   Guerrero Romero, Fernando ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b NONE   (Mexico)

Author keywords

Hypomagnesemia; Insulin resistance; Magnesium; NASH; Obesity; Steatohepatitis; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; MAGNESIUM ION;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ANALYSIS; ENZYME ASSAY; FEMALE; HUMAN; HYPOMAGNESEMIA; INSULIN RESISTANCE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY;

ADULT; AGED; BIOPSY; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; HYPOPIGMENTATION; INFLAMMATION; INSULIN RESISTANCE; LIVER; MAGNESIUM; MALE; MIDDLE AGED; OBESITY;

EID: 20444414868     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.03.008     Document Type: Article

References (42)

1. A. Reid Nonalcoholic steatohepatitis Gastroenterology 121 2001 710 723
2. Z. Younossi, A.M. Diehl, and J.P. Ong Nonalcoholic fatty liver disease: an agenda for clinical research Hepatology 35 2002 746 752
3. V. Paradis, G. Perlemuter, F. Bonvoust, D. Dargere, B. Parfait, M. Vidaud, M. Conti, S. Huet, N. Ba, C. Buffet, and P. Bedossa High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis Hepatology 34 2001 738 744
4. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, and A.J. McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
5. X. Poonawala, P.N. Satheesh, and P.J. Thuluvath Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study Hepatology 32 2000 689 692
6. H. King, and M. Rewers Diabetes in adults is now a triad world problem The WHO Ad Hoc Diabetes Working Group 69 1991 Bull WHO Geneva 643-648
7. S. Bellentani, G. Saccoccio, F. Masutti, L.S. Croce, G. Brandi, F. Sasso, G. Cristanini, and C. Tiribelli Prevalence of and risk factors for hepatic steatosis in northern Italy Ann Intern Med 132 2000 112 117
8. S.S. Jick, M. Stender, and M.W. Myers Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents Diabetes Care 22 1999 1067 1071
9. P. Angulo, and L. Keith Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issue Gastroenterology 120 2001 1281 1285
10. G. Pagano, G. Pacini, G. Musso, R. Gambino, F. Mecca, N. Depetris, M. Cassader, E. David, P. Cavallo-Perin, and M. Rizzetto Nonalcoholic steatohepatitis, insulin resístance, and metabolic syndrome: further evidence for an etiologic association Hepatology 35 2002 367 372
11. G. Marchesini, and G. Forlani NASH: from liver disease to metabolic disorders and back to clinical hepatology Hepatology 35 2002 497 499
12. S. Chitturi, S. Abeygunasekera, G.C. Farrell, J. Holmes-Walker, J.M. Hui, C. Fung, R. Karim, R. Lin, D. Samarasinghe, C. Liddle, M. Weltman, and J. George NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 2002 373 379
13. F. Guerrero-Romero, and M. Rodríguez-Morán Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values J Diabetes Complications 14 2000 272 276
14. F. Guerrero-Romero, and M. Rodríguez-Morán Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects Int J Obes Relat Metab Disord 26 2002 469 474
15. P.A. Marken, C.W. Weart, D.S. Carson, J.G. Gums, and M.F. Lopes-Virella Effects of magnesium oxide on the lipid profile of healthy volunteers Atherosclerosis 77 1989 37 42
16. S. Humphries, H. Kushner, and B. Falkner Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans Am J Hypertens 12 1999 747 756
17. H. Rosolova, O. Mayer Jr., and G. Reaven Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects J Clin Endocrinol Metab 82 1997 3783 3785
18. J.L. Nadler, T. Buchanan, R. Natarajan, I. Antonipillai, R. Bergman, and R. Rude Magnesium deficiency produces insulin resistance and increased thromboxane synthesis Hypertension 21 1993 1024 1029
19. W.H.L. Kao, A.R. Folsom, J.F. Nieto, J.P. Mo, R.L. Watson, and F.L. Brancati Serum and dietary magnesium and the risk for type 2 diabetes mellitus Arch Intern Med 159 1999 2151 2159
20. M. Rodríguez-Morán, and F. Guerrero-Romero Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes Arch Med Res 32 2001 300 303
21. D. Matthews, J. Hosker, A. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
22. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care Suppl 1 1999 S5 S19
23. R.R. Sokal, and F.J. Rohlf Biometria. Principios y métodos estadísticos en la investigación biológica Madrid: H. Blume Ediciones 1979 281 329
24. K. Bojanowicz, and C. Skarbek-Galamon Disturbances of fat, carbohydrate, magnesium and protein balance in liver disease Acta Hepatogastroenterol 24 1997 155 161
25. H. Korpela Hypothesis: increased calcium and decreased magnesium in heart muscle and liver of pigs dying suddenly of microangiopathy (mulberry heart disease): an animal model for the study of oxidative damage J Am Coll Nutr 10 1991 127 131
26. O.M. Alarcón, J.L. Burguera, M. Burguera, T.M. Silva, L.F. Ferrer, and T.J. Romero Effects of acute overdose of vitamin A on the hepatic content of K, Na, Mg, Fe, Cu, and Zn in rats Arch Latinoam Nutr 44 1994 249 251
27. G. Faa, M. Lisci, M.P. Caria, R. Ambu, R. Sciot, V.M. Nurchi, R. Silvagni, A. Diaz, and G. Crisponi Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson's disease J Trace Elem Med Biol 15 2001 155 160
28. H. Saha, A. Harmoinen, A.L. Karvonen, J. Mustonen, and A. Pasternack Serum ionized versus total magnesium in patients with intestinal or liver disease Clin Chem Lab Med 36 1998 715 718
29. B. Oralewska, J. Zawadzki, I. Jankowska, K. Popinska, and J. Socha Disorders of magnesium homeostasis in the course of liver disease in children Magnes Res 9 1996 125 128
30. Q. Zhou, M.M. Mahfouz, and F.A. Kumerow Effect of dietary magnesium deficiency with/without cholesterol supplementation on phospholipid content in liver, plasma and erythrocytes of rabbits Magnes Res 7 1994 23 30
31. P. Pasqualetti, R. Casale, D. Colantonio, G. Di Lauro, V. Festuccia, L. Natali, and G. Natali Serum levels of magnesium in hepatic cirrhosis (abstract) Quad Sclavo Diagn 23 1987 12 17
32. S. Bellentani, G. Saccoccio, and F. Massutti Prevalence of and risk factors for hepatic steatosis in northern Italy Ann Intern Med 132 2000 112 117
33. B.R. Bacon, M.J. Farahvash, C.G. Janney, and B.A. Neuschwander-Tetri Nonalcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 1994 1103 1109
34. S. Matthaei, M. Stumvoll, M. Kellerer, and H.U. Haring Pathophysiology and pharmacological treatment of insulin resistance Endocr Rev 21 2000 585 618
35. B.L. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocr Rev 21 2000 697 738
36. S.A. Harrison, S. Kadakia, K.A. Lang, and S. Schenker Nonalcoholic steatohepatitis: what we know in the new millennium Am J Gastroenterol 97 2002 2714 2724
37. F.W. Heaton, and P. Ellie Metabolic activity of liver mitochondria from magnesium-deficient rats Magnesium 3 1984 21 28
38. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
39. A. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, R.K. Sterling, V.A. Luketic, M.L. Shiffman, and J.N. Clore Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192
40. A.J. Sanyal AGA technical review of nonalcoholic fatty liver disease Gastroenterology 123 2002 1705 1725
41. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis of an AASLD single topic conference Hepatology 37 2003 1202 1219
42. W.R. Külpmann, J. Rössler, R. Brunkhorst, and A. Shuler Ionised and total magnesium serum concentrations in renal and hepatic diseases Eur J Clin Chem Clin Biochem 34 1996 257 264